Letter

NICE on dementia

Omitting donepezil is hardly a hardship

BMJ 2007; 335 doi: 10.1136/bmj.39388.433137.1F (Published 8 November 2007)
Cite this as: BMJ 2007;335:954.1

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Thomas E Finucane, professor of medicine
  1. Johns Hopkins University School of Medicine, Burton Pavilion, 5505 Hopkins Bayview Circle, Baltimore, MD 21224, USA
  1. tfinucan{at}jhmi.edu

    To condemn the National Institute for Health and Clinical Excellence (NICE) as ageist when it limits access to donepezil is to …

    Access to the full text of this article requires a subscription or payment

    Subscribe

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    Rapid responses

    THIS WEEK'S POLL

    BMJ most popular